Partnerships
IMU Powers Drug Discovery & Clinical Breakthroughs
IMU collaborates with clinical research groups, pharmaceutical, biotech and diagnostics companies to identify and deploy clinically actionable immune signatures that advance precision medicine.
Partnering with IMU
01
Decode Disease Biology
- Discovery of novel immune signatures of disease
- Discovery of mechanistic insights into treatment success, resistance and toxicity
- Identification of new therapeutic targets and immune-driven pathways
- Identification of biomarkers for early diagnosis and disease endotyping
02
Optimise Clinical Development
- Prediction of likely responders and non-responders
- Enablement of patient stratification and selection to improve trial outcomes
- Identification of biomarkers for study design and endpoint selection
- Prediction and monitoring of immune-related adverse events
03
Advance Precision Medicine
- Development of biomarker-driven diagnostics
- Improved donor selection for transplantationÂ
- Personalised drug selection, drug titration and patient monitoring
- Delivery of companion diagnostics for clinical implementation
